SAN MATEO, Calif.–(BUSINESS WIRE)–Cala, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, today announced that the Centers for Medicare & Medicaid Services (CMS) has set a payment determination and benefit category for the existing unique Healthcare Common Procedure Coding System (HCPCS) code K1018 for Cala TAPS therapy, initially put into effect in 2021. This decision, effective October 1, 2022, expands access for Medicare patients with essential tremor (ET) who could benefit from Cala TAPS therapy.
Cala Receives Pricing from CMS for Cala TAPS Therapy to Expand Medicare Patient Access
Posted on October 17, 2022
Categories: ET Treatment, In the News